|
1.
|
|
6 p, 429.2 KB |
Decision-making in HIV clinical trials : a study with patients enrolled in antiretroviral trials Toma de decisiones en los ensayos clínicos sobre el VIH: estudio con pacientes incluidos en ensayos de antirretrovirales
/
Feijoo-Cid, Maria (Universitat Autònoma de Barcelona. Departament d'Infermeria) ;
Rivero-Santana, Amado (Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC)) ;
Moriña, David (Universitat Autònoma de Barcelona. Departament de Matemàtiques) ;
Cesar, Carina (Fundación Huésped) ;
Fink, Valeria (Fundación Huésped, Buenos Aires, Argentina) ;
Sued, Omar (Fundación Huésped, Buenos Aires, Argentina)
Objective: To explore the decisional process of people living with human immunodeficiency virus (HIV) currently enrolled in antiretroviral clinical trials. Method: Cross-sectional retrospective study. [...]
2021 -  10.1016/j.gaceta.2019.11.008
Gaceta sanitaria, Vol. 35 Núm. 3 (Mayo 2021) , p. 264-269
|
|
|
2.
|
|
|
3.
|
|
8 p, 254.6 KB |
Prevalence, evolution, and related risk factors of kidney disease among Spanish HIV-infected individuals
/
Juega-Mariño, Javier (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Bonjoch, Anna (Institut Germans Trias i Pujol. Fundació de Lluita Contra la Sida) ;
Pérez-Álvarez, Núria (Institut Germans Trias i Pujol. Fundació de Lluita Contra la Sida) ;
Negredo Puigmal, Eugènia (Institut Germans Trias i Pujol. Fundació de Lluita Contra la Sida) ;
Bayés Genís, Beatriu (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Bonet Sol, Josep (Universitat Autònoma de Barcelona) ;
Clotet Sala, Bonaventura (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Romero, Ramon (Universitat Autònoma de Barcelona. Departament de Medicina)
Prevalence of kidney disease (KD) is increasing among human immunodeficiency virus (HIV)-infected population. Different factors have been related, varying on different published series. The objectives were to study prevalence of KD in those patients, its evolution, and associated risk factors. [...]
2017 - 10.1097/MD.0000000000007421
Medicine, Vol. 96 (september 2017)
|
|
|
4.
|
|
12 p, 2.3 MB |
Benzyl-2-Acetamido-2-Deoxy-α--Galactopyranoside Increases Human Immunodeficiency Virus Replication and Viral Outgrowth Efficacy In Vitro
/
Olvera, Alex (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Martinez, Javier P. (Universitat Pompeu Fabra. Departament de Ciències Experimentals i de la Salut) ;
Casadellà, Maria (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Llano Montero, Anuska (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Rosás, Míriam (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Mothe, Beatriz (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Ruiz-Riol, Marta (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Arsequell, Gemma (Institut de Química Avançada de Catalunya) ;
Valencia, Gregorio (Institut de Química Avançada de Catalunya) ;
Noguera-Julian, Marc (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Paredes, Roger (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Meyerhans, Andreas (Institució Catalana de Recerca i Estudis Avançats) ;
Brander, Christian (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa)
Glycosylation of host and viral proteins is an important posttranslational modification needed to ensure correct function of glycoproteins. For this reason, we asked whether inhibition of O-glycosylation during human immunodeficiency virus (HIV) in vitro replication could affect HIV infectivity and replication rates. [...]
2018 - 10.3389/fimmu.2017.02010
Frontiers in immunology, Vol. 8 (january 2018)
|
|
|
5.
|
|
11 p, 823.4 KB |
Monitoring hepatitis C virus treatment rates in an Opioid Treatment Program : A longitudinal study
/
Sanvisens, Arantza (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Rivas, Inmaculada (Badalona Serveis Assistencials) ;
Faure, Eva (Badalona Serveis Assistencials) ;
Espinach, Néstor (Badalona Serveis Assistencials) ;
Hernandez-Rubio, Anna (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Majó, Xavier (Servei Català de la Salut) ;
Colom, Joan (Colom Farran) (Servei Català de la Salut) ;
Muga, Roberto (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Universitat Autònoma de Barcelona
Direct-acting antivirals (DAAs) are recommended for the treatment of hepatitis C virus (HCV) infection in patients treated with methadone or buprenorphine. To assess HCV treatment rates in an Opioid Treatment Program (OTP). [...]
2020 - 10.3748/wjg.v26.i38.5874
World Journal of Gastroenterology, Vol. 26 Núm. 38 (october 2020) , p. 5874-5883
|
|
|
6.
|
|
12 p, 754.4 KB |
Adherence to antiretroviral therapy and the associated factors among people living with HIV/AIDS in Northern Peru : a cross-sectional study
/
Leyva-Moral, Juan M. (Universitat Autònoma de Barcelona. Departament d'Infermeria) ;
Loayza-Enriquez, Blanca K. (Universidad Nacional Pedro Ruiz Gallo) ;
Palmieri, Patrick A. (A. T. Still University) ;
Guevara-Vasquez, Genesis M. (Universidad María Auxiliadora (Perú)) ;
Elias-Bravo, Ursula E. (Hospital Regional Lambayeque (Perú)) ;
Edwards, Joan E. (Texas Woman's University) ;
Feijoo Cid, Maria (Universitat Autònoma de Barcelona. Departament d'Infermeria) ;
Davila-Olano, Lucy Y. (Hospital Regional Lambayeque (Perú)) ;
Rodriguez-Llanos, Juan R. (Hospital Regional Lambayeque (Perú)) ;
Leon-Jimenez, Franco E. (Hospital Regional Lambayeque (Perú))
There are approximately 72,000 people living with HIV/AIDS (PLHIV) in Peru. Non-adherence to antiretroviral therapy (ART) is the most important factor for therapeutic failure and the development of resistance. [...]
2019 - 10.1186/s12981-019-0238-y
AIDS Research and Therapy, Vol. 16 (august 2019)
|
|
|
7.
|
|
|
8.
|
|
0 p, 5.4 MB |
Antigen production after latency reversal and expression of inhibitory receptors in CD8+ T cells limit the killing of HIV-1 reactivated cells
/
Ruiz, A. (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Blanch-Lombarte, Oscar (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Jiménez-Moyano, Esther (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Ouchi, Dan (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Mothe, Beatriz. (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Peña, R. (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Gálvez, Cristina (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Genescà Ferrer, Meritxell. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Martínez Picado, Francisco Javier (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Goulder, P. (Department of Paediatrics. University of Oxford) ;
Barnard, R. (Department of Infectious Disease. Merck and Co. Inc.) ;
Howell, B. (Department of Infectious Disease. Merck and Co. Inc.) ;
Pérez-Álvarez, Núria (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Prado, Julia G.. (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Universitat Autònoma de Barcelona
The so-called shock and kill therapies aim to combine HIV-1 reactivation by latency-reversing agents (LRA) with immune clearance to purge the HIV-1 reservoir. The clinical use of LRA has demonstrated detectable perturbations in the HIV-1 reservoir without measurable reductions to date. [...]
2019 - 10.3389/fimmu.2018.03162
Frontiers in immunology, Vol. 10 Núm. JAN (2019) , p. 3162
|
|
|
9.
|
|
25 p, 2.8 MB |
Detailed Characterization of Early HIV-1 Replication Dynamics in Primary Human Macrophages
/
Bejarano, David Alejandro (Department of Infectious Diseases, Virology. University of Heidelberg. Heidelberg, Germany) ;
Puertas, Maria C.. (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Börner, Kathleen (German Center for Infection Research, Partner Site Heidelberg. Heidelberg, Germany) ;
Martinez-Picado, Javier (Institució Catalana de Recerca i Estudis Avançats) ;
Müller, Barbara (Department of Infectious Diseases, Virology, University of Heidelberg. Heidelberg, Germany) ;
Kräusslich, Hans-Georg (German Center for Infection Research, Partner Site Heidelberg. Heidelberg, Germany)
Macrophages are natural target cells of human immunodeficiency virus type 1 (HIV-1). Viral replication appears to be delayed in these cells compared to lymphocytes; however, little is known about the kinetics of early post-entry events. [...]
2018 - 10.3390/v10110620
Viruses, Vol. 10 (november 2018)
|
|
|
10.
|
|
12 p, 1.2 MB |
Identification of HIV-1-Based Virus-like Particles by Multifrequency Atomic Force Microscopy
/
González-Domínguez, Irene (Universitat Autònoma de Barcelona. Departament d'Enginyeria Química, Biològica i Ambiental) ;
Gutiérrez Granados, Sonia (Universitat Autònoma de Barcelona. Departament d'Enginyeria Química, Biològica i Ambiental) ;
Cervera Gracia, Laura (Universitat Autònoma de Barcelona. Departament d'Enginyeria Química, Biològica i Ambiental) ;
Gòdia, Francesc (Universitat Autònoma de Barcelona. Departament d'Enginyeria Química, Biològica i Ambiental) ;
Domingo Marimon, Neus (Institut Català de Nanociència i Nanotecnologia)
Virus-like particles (VLPs) have become a promising platform for vaccine production. VLPs are formed by structural viral proteins that inherently self-assemble when expressed in a host cell. They represent a highly immunogenic and safe vaccine platform, due to the absence of the viral genome and its high protein density. [...]
2016 - 10.1016/j.bpj.2016.07.046
Biophysical Journal, Vol. 111, Núm. 6 (September 2016) , p. 1173-1179
|
|
visitant ::
identificació
alerta personal via correu electrònic o subscribiu-vos al 
canal RSS.
